Janus Henderson Group PLC Janux Therapeutics, Inc. Transaction History

Janus Henderson Group PLC

  • $174 Billion
  • Q1 2025

A detailed history of Janus Henderson Group PLC transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 4,598,092 shares of JANX stock, worth $128 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
4,598,092
Previous 3,562,402 29.07%
Holding current value
$128 Million
Previous $191 Million 34.91%
% of portfolio
0.07%
Previous 0.1%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$27.0 - $57.81 $28 Million - $59.9 Million
1,035,690 Added 29.07%
4,598,092 $124 Million
Q4 2024

Feb 14, 2025
BUY
$40.18 - $66.83 $41.7 Million - $69.4 Million
1,038,996 Added 41.17%
3,562,402 $191 Million
Q3 2024

Nov 14, 2024
BUY
$35.29 - $50.26 $25.5 Million - $36.3 Million
721,563 Added 40.05%
2,523,406 $115 Million
Q2 2024

Aug 14, 2024
SELL
$35.12 - $64.78 $5.75 Million - $10.6 Million
-163,703 Reduced 8.33%
1,801,843 $75.5 Million
Q1 2024

May 15, 2024
BUY
$7.93 - $49.75 $270,167 - $1.69 Million
34,069 Added 1.76%
1,965,546 $74 Million
Q4 2023

Feb 14, 2024
SELL
$5.85 - $11.7 $795,547 - $1.59 Million
-135,991 Reduced 6.58%
1,931,477 $20.7 Million
Q3 2023

Nov 14, 2023
SELL
$9.56 - $14.0 $400,277 - $586,180
-41,870 Reduced 1.98%
2,067,468 $20.8 Million
Q2 2023

Aug 14, 2023
BUY
$11.08 - $15.92 $2.66 Million - $3.82 Million
240,262 Added 12.85%
2,109,338 $25 Million
Q1 2023

May 15, 2023
BUY
$11.25 - $22.21 $351,956 - $694,839
31,285 Added 1.7%
1,869,076 $22.6 Million
Q4 2022

Feb 14, 2023
SELL
$11.1 - $18.26 $1.36 Million - $2.23 Million
-122,253 Reduced 6.24%
1,837,791 $24.2 Million
Q3 2022

Nov 14, 2022
SELL
$10.82 - $16.84 $1.82 Million - $2.82 Million
-167,753 Reduced 7.88%
1,960,044 $26.5 Million
Q2 2022

Aug 15, 2022
SELL
$9.52 - $15.65 $2.01 Million - $3.31 Million
-211,349 Reduced 9.04%
2,127,797 $26 Million
Q1 2022

May 16, 2022
SELL
$13.24 - $20.24 $817,530 - $1.25 Million
-61,747 Reduced 2.57%
2,339,146 $33.5 Million
Q4 2021

Feb 14, 2022
SELL
$15.44 - $27.32 $239,489 - $423,760
-15,511 Reduced 0.64%
2,400,893 $46.6 Million
Q3 2021

Nov 16, 2021
SELL
$20.7 - $34.69 $5.21 Million - $8.74 Million
-251,803 Reduced 9.44%
2,416,404 $51.4 Million
Q2 2021

Aug 16, 2021
BUY
$18.58 - $25.37 $49.6 Million - $67.7 Million
2,668,207 New
2,668,207 $64.5 Million

Others Institutions Holding JANX

# of Institutions
190
Shares Held
57.3M
Call Options Held
626K
Put Options Held
155K
View Full List

About Janux Therapeutics, Inc.

JANX Quotes by TradingView
  • Ticker JANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,663,000
  • Market Cap $1.16B
  • Description
  • Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...
More about JANX
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email